EU regulators have launched two public electronic catalogs of real-world data (RWD) sources and studies that they believe will better help drug companies, regulators and researchers identify and use such data when investigating the use, safety and effectiveness of medicines.
The catalogs introduce various improvements to the EU’s former RWD databases such as improved interoperability between studies and data sources, according to the European Medicines Agency and the bloc’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?